Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma
Clinical trial NCT01833767 · WITHDRAWN
Trial details
- NCT number
- NCT01833767
- Sponsor
- Western Regional Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.